Liwen Zhou
About Liwen Zhou
Liwen Zhou is an Executive Director at UBS, where he has worked since 2022, focusing on expanding the derivatives business in China. He previously held senior roles at Essence Securities and Huaxin Securities, where he contributed to significant advancements in financial products and compliance.
Current Role at UBS
Liwen Zhou serves as an Executive Director at UBS, a position he has held since January 2022. In this role, he is responsible for expanding the derivatives business in China. His leadership at UBS focuses on enhancing the firm's capabilities in the financial markets, particularly in the area of derivatives.
Previous Experience at Essence Securities
Before joining UBS, Liwen Zhou worked at Essence Securities Co., Ltd as a Senior OTC Derivatives Sales & Product Manager from 2014 to 2017. During his tenure, he contributed to the growth of the OTC derivatives market in China, leveraging his expertise in financial products and sales strategies.
Educational Background
Liwen Zhou holds a Bachelor's degree in Economics & Finance from The University of Hong Kong, where he studied from 2007 to 2010. He furthered his education by obtaining a Master of Science in Financial Analysis from the University of San Francisco in 2012. Additionally, he participated in a summer session at the Haas Business School, University of California, Berkeley, in 2009.
Leadership Roles at Huaxin Securities
Liwen Zhou held multiple leadership roles at Huaxin Securities from 2017 to 2021, including the position of Head of Financial Innovation Department. He established the Financial Markets Department, focusing on compliance, risk control, and client needs, which quickly gained industry recognition and generated stable profits.
Pioneering Contributions to OTC Options
In 2015, Liwen Zhou pioneered the design and launch of the single-stock OTC options business in China. This initiative marked a significant development in the financial markets, showcasing his ability to innovate and lead in a competitive environment.